PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.39%
Negative gross profit growth while 1113.HK is at 9.85%. Joel Greenblatt would examine cost competitiveness or demand decline.
-399.43%
Negative EBIT growth while 1113.HK is at 35.23%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.34%
Negative operating income growth while 1113.HK is at 30.09%. Joel Greenblatt would press for urgent turnaround measures.
-714.16%
Negative net income growth while 1113.HK stands at 22.74%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-713.16%
Negative EPS growth while 1113.HK is at 23.23%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-713.16%
Negative diluted EPS growth while 1113.HK is at 21.72%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Slight or no buybacks while 1113.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.24%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
45.21%
Positive FCF growth while 1113.HK is negative. John Neff would see a strong competitive edge in net cash generation.
178562.95%
10Y revenue/share CAGR above 1.5x 1113.HK's 104.57%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
178.11%
Positive 5Y CAGR while 1113.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
28.80%
Positive 3Y CAGR while 1113.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
366.34%
Positive long-term OCF/share growth while 1113.HK is negative. John Neff would see a structural advantage in sustained cash generation.
321.78%
Positive OCF/share growth while 1113.HK is negative. John Neff might see a comparative advantage in operational cash viability.
216.09%
3Y OCF/share CAGR 1.25-1.5x 1113.HK's 156.10%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
79.08%
Net income/share CAGR 1.25-1.5x 1113.HK's 67.06%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
83.79%
Positive 5Y CAGR while 1113.HK is negative. John Neff might view this as a strong mid-term relative advantage.
-129.55%
Negative 3Y CAGR while 1113.HK is 143.77%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-35.33%
Negative equity/share CAGR over 10 years while 1113.HK stands at 1643.82%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
23.77%
5Y equity/share CAGR is in line with 1113.HK's 24.22%. Walter Schloss would see parallel mid-term profitability and retention policies.
-0.97%
Negative 3Y equity/share growth while 1113.HK is at 16.60%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.18%
Inventory is declining while 1113.HK stands at 0.85%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.13%
Positive asset growth while 1113.HK is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.66%
We have a declining book value while 1113.HK shows 2.82%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-7.72%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-2.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.